Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer

The ExactVu™ Micro-Ultrasound system is a new high resolution imaging system for visualizing the prostate and has been FDA, CE, and Health Canada approved for visualization and biopsy of the prostate. The PRI-MUS™ (Prostate Risk Identification for Micro-Ultrasound) protocol has previously been demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghai, Sangeet, Van der Kwast, Theodorus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711692/
https://www.ncbi.nlm.nih.gov/pubmed/29204363
http://dx.doi.org/10.1016/j.eucr.2017.11.013
_version_ 1783283077249761280
author Ghai, Sangeet
Van der Kwast, Theodorus
author_facet Ghai, Sangeet
Van der Kwast, Theodorus
author_sort Ghai, Sangeet
collection PubMed
description The ExactVu™ Micro-Ultrasound system is a new high resolution imaging system for visualizing the prostate and has been FDA, CE, and Health Canada approved for visualization and biopsy of the prostate. The PRI-MUS™ (Prostate Risk Identification for Micro-Ultrasound) protocol has previously been demonstrated to correlate with risk of prostate cancer and severity of cancer. Here we present a case where a healthy 50 year old subject with no known risk factors volunteered to test the ExactVu system and was found to harbour multiple PRI-MUS 3–5 lesions. This prompted PSA testing, biopsy and eventual diagnosis of significant prostate cancer.
format Online
Article
Text
id pubmed-5711692
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57116922017-12-04 Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer Ghai, Sangeet Van der Kwast, Theodorus Urol Case Rep Oncology The ExactVu™ Micro-Ultrasound system is a new high resolution imaging system for visualizing the prostate and has been FDA, CE, and Health Canada approved for visualization and biopsy of the prostate. The PRI-MUS™ (Prostate Risk Identification for Micro-Ultrasound) protocol has previously been demonstrated to correlate with risk of prostate cancer and severity of cancer. Here we present a case where a healthy 50 year old subject with no known risk factors volunteered to test the ExactVu system and was found to harbour multiple PRI-MUS 3–5 lesions. This prompted PSA testing, biopsy and eventual diagnosis of significant prostate cancer. Elsevier 2017-11-21 /pmc/articles/PMC5711692/ /pubmed/29204363 http://dx.doi.org/10.1016/j.eucr.2017.11.013 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Ghai, Sangeet
Van der Kwast, Theodorus
Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
title Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
title_full Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
title_fullStr Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
title_full_unstemmed Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
title_short Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
title_sort suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711692/
https://www.ncbi.nlm.nih.gov/pubmed/29204363
http://dx.doi.org/10.1016/j.eucr.2017.11.013
work_keys_str_mv AT ghaisangeet suspiciousfindingsonmicroultrasoundimagingandearlydetectionofprostatecancer
AT vanderkwasttheodorus suspiciousfindingsonmicroultrasoundimagingandearlydetectionofprostatecancer

Ejemplares similares